CHINA MEHECO GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.98 CNY | +0.73% |
|
-1.79% | -1.70% |
| Feb. 20 | Meheco's Unit Gets Nod to Raise Specifications for Piperacillin Sodium for Injection | MT |
| Feb. 20 | Argatroban Injection of Meheco's Subsidiary Passes Chinese Drug Regulator's Evaluation | MT |
ETFs positioned on China Meheco Group Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.47% | 2 M€ | -16.59% | - | |
| 0.01% | 2,808 M€ | +5.90% | - | |
| 0.01% | 441 M€ | +4.60% | - | |
| 0.01% | 149 M€ | +2.17% | - | |
| 0.00% | 4 M€ | -4.41% | - | |
| 0.00% | 31 M€ | +3.50% | - | |
| 0.00% | 34 M€ | +2.14% | - | |
| 0.00% | 15 M€ | +11.24% |
China Meheco Group Co., Ltd. is mainly engaged in the operation of industrial pharmaceutical, commercial pharmaceutical and international trading businesses. Industrial Pharmaceutical segment mainly involves in the manufacture and distribution of chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, herbal decoction pieces and other pharmaceutical products. Commercial Pharmaceutical segment is mainly engaged in the wholesale and distribution of pharmaceuticals and medical devices. Trading segment is mainly engaged in the international exporting business and medical resourcing introduction.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -1.70% | 2.27B | |
| +17.35% | 71.39B | |
| +5.38% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -3.38% | 3.93B | |
| -2.61% | 3.86B | |
| +22.08% | 3.64B |
- Stock Market
- Equities
- 600056 Stock
- Funds and ETFs China Meheco Group Co., Ltd.
